Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between carfilzomib and panobinostat

Results for the following 2 drugs:
carfilzomib
panobinostat

Interactions between your drugs

There were no interactions found in our database between carfilzomib and panobinostat - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

carfilzomib

A total of 303 drugs (1319 brand and generic names) are known to interact with carfilzomib.

panobinostat

A total of 853 drugs (4716 brand and generic names) are known to interact with panobinostat.

Drug and food interactions

Moderate

panobinostat food

Applies to: panobinostat

Do not consume grapefruit, grapefruit juice, star fruit, pomegranate, or pomegranate juice during treatment with panobinostat. Doing so can increase blood levels of the medication. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; fatigue; swelling in the arms or legs; heart problems (e.G., chest pain, heart failure, irregular heartbeat); liver problems; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide